FDA.reportPublic FDA data

Bepreve 1.5 % Ophthalmic Solution

RxCUI
863042
RxNorm name
Bepreve 1.5 % Ophthalmic Solution
Display name
Bepreve 1.5 % Ophthalmic Solution
Full name
Bepreve 1.5 % Ophthalmic Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BepreveBEPOTASTINE BESILATEBausch & Lomb Incorporated68bbf6a0-c4b5-47c1-8a1c-08220fbdbce62022-08-31Warnings, Adverse reactionsExact identifier
rxcui: 863042

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6BEPREVE 1.5 % Ophthalmic Solution [PSN] · bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve] [SBD] · Bepreve 1.5 % Ophthalmic Solution [SY] · Bepreve 15 MG/ML Ophthalmic Solution [SY]414These highlights do not include all the information needed to use BEPREVE safely and effectively. See full prescribing information for BEPREVE. BEPREVE ® (bepotastine besilate ophthalmic solution), for topical ophthalmic use Initial U.S. Approval: 200920220831
7c77517f-24c7-4778-94a7-873d11c3c657BEPREVE 1.5 % Ophthalmic Solution [PSN] · bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve] [SBD] · Bepreve 1.5 % Ophthalmic Solution [SY] · Bepreve 15 MG/ML Ophthalmic Solution [SY]41These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™. BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% Initial U.S. Approval: 200920090801